REGARDS DNA Extraction and Quantification

Closed Special Notice Posted

Solicitation number
NIH-NOI-PCA-NIA-01601
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Colchester, Vermont 05446, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Aging (NIA), Center for Alzheimer's and Related Dementias (CARD), issued a Notice of Intent to Sole Source on June 11, 2026, for DNA extraction and quantification services with a response deadline of June 23, 2026, 11:00 AM Eastern Time. The Government intends to award a firm-fixed-price sole source contract to University of Vermont Laboratory for Clinical Biochemistry Research, Colchester, VT, based on 41 U.S.C. 3304(a)(1) and FAR 6.302-1, asserting that only the University of Vermont possesses custody and access to the proprietary REGARDS participant biospecimens and repository required.

The contract will support the Reasons for Geographic and Racial Difference in Stroke (REGARDS) genome-wide association study. The contractor shall perform DNA extraction, quantification, and repository handling for approximately 12,000 participant biospecimens using the Qiagen Puregene DNA Purification Kit and PicoGen analysis. Deliverables include extracted DNA samples at concentrations of 50 ng/uL or greater with a minimum of 1 microgram per sample, quantification results, identification of failed extractions, and quarterly progress reports. The period of performance runs July 1, 2026 through June 30, 2029. Work is performed at the contractor's site with no travel requirements. Capable sources may submit capability statements by June 23, 2026, demonstrating access to REGARDS biospecimens and repository services, though the Government will not reimburse submission costs.

Notice text

Title: Notice of Intent to Sole Source – REGARDS DNA Extraction and Quantification

Notice ID: NIH-NOI-PCA-NIA-01601

Department/Ind. Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier: NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTE ON AGING

Active Contract Opportunity

Notice Type: Special Notice

Original Published Date: June 11, 2026
Original Response Date: June 23, 2026, 11:00 AM Eastern Time
Initiative: None

Classification

Original Set Aside: N/A
Product Service Code: 6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
NAICS Code: 541380 – Testing Laboratories and Services

Place of Performance

Primary Place of Performance:
University of Vermont Laboratory for Clinical Biochemistry Research
Colchester Research Facility
360 South Park Drive, Room 224
Colchester, VT 05446
United States

Description

This is a Notice of Intent to Sole Source and is not a request for competitive proposals, quotations, or bids.

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Aging (NIA), Center for Alzheimer’s and Related Dementias (CARD), intends to negotiate and award a sole source firm-fixed-price contract to:

University of Vermont Laboratory for Clinical Biochemistry Research
Colchester Research Facility
360 South Park Drive, Room 224
Colchester, VT 05446

The purpose of this requirement is to obtain specialized laboratory support services for the Reasons for Geographic and Racial Difference in Stroke (REGARDS) project. The contractor shall perform DNA extraction, DNA quantification, repository handling, preparation, and shipment of extracted DNA samples for approximately 12,000 REGARDS participant biospecimens in support of a genome-wide association study (GWAS).

The contractor shall:

  • Evaluate frozen packed cell sample availability in the REGARDS repository;
  • Select and pull samples from the repository in batches;
  • Perform manual DNA extraction using the Qiagen Puregene DNA Purification Kit;
  • Perform DNA quantification using PicoGreen;
  • Create cryovials of DNA for the REGARDS repository;
  • Create and maintain tracking inventory for extracted DNA samples;
  • Prepare 1 ug or more DNA per sample at a concentration of 50 ng/uL or greater;
  • Ship extracted DNA samples to CARD facilities;
  • Provide DNA quantification results to the Government; and
  • Identify any samples for which extraction failed.

The anticipated period of performance is July 1, 2026 through June 30, 2029.

The statutory authority for this sole source acquisition is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The University of Vermont Laboratory for Clinical Biochemistry Research is the only known source capable of meeting the Government’s requirement because it designed and led the biosample collection effort for the REGARDS study, maintains the REGARDS biosample repository, serves as the REGARDS central analysis laboratory, and has custody of and access to the proprietary, unique, and non-replaceable REGARDS participant biospecimens required for this effort. Although other commercial laboratories may provide general DNA extraction and quantification services, no other source is known to possess the proprietary REGARDS starting samples or repository access required to perform this requirement.

This notice is not a solicitation. However, any responsible source that believes it is capable of meeting the Government’s requirement may submit a capability statement demonstrating its ability to satisfy the requirement described herein. Responses must clearly demonstrate the offeror’s capability to provide access to the proprietary REGARDS biospecimens and repository services, as well as the required DNA extraction, quantification, handling, and shipment services.

All capability statements received by the response date and time will be considered by the Government. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government.

No solicitation document is available. The Government will not reimburse respondents for any costs associated with submission of capability statements.

Attachments/Links

None at this time.

Contact Information

Primary Point of Contact

Linda Smith
Contracting Officer
linda.smith2@nih.gov

Secondary Point of Contact

Danielle Tines
Procurement Technician
danielle.tines@nih.gov

Files

File Type Posted
SOW.pdf PDF
NOI.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
NOI - A Non-Invasive Prognostic Biomarker NAICS 541714 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories NAICS 541714 National Institute on Drug Abuse No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity